Combat Diabetic Nephropathy: From Pathogenesis to Treatment
1Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
2Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Kahoku, Ishikawa 920-0293, Japan
3Department of Nephrology, Graduate School of Medicine, Institute of Health Biosciences, University of Tokushima, Tokushima 770-8503, Japan
4Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University Sangil-Dong 149, Gangdong-gu, Seoul 134-727, Korea
Combat Diabetic Nephropathy: From Pathogenesis to Treatment
Description
Diabetic nephropathy is the most common microvascular complication of diabetes and remains one of the leading causes of end-stage renal disease worldwide. Understanding the molecular mechanisms involved in the development/progression of diabetic nephropathy is important to identify novel therapeutic targets for therapy. Not only nephrologist and endocrinologist but also all internal physicians combat this disease. We invite submissions of original research or review articles on pathophysiologic mechanisms involved in the development/progression of diabetic nephropathy. Potential topics include, but are not limited to:
- Inflammation and fibrosis in diabetic nephropathy
- Aging in diabetic nephropathy
- Genetics in diabetic nephropathy
- AGEs in diabetic nephropathy
- Oxidative stress in diabetic nephropathy
- Biomarkers in diabetic nephropathy
- Treatment of hypertension, hyperglycemia, and hyperlipidemia in diabetic nephropathy
Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jdr/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jdr/cdne/ according to the following timetable: